From January 1st, 2024, Polykon Manufacturing LLC, which operates as a production plant in Richmond, Virginia, U.S. win be merged inio its parent company, Seppic, Inc. ("Seppic'). This change brings coherence to the organization of Seppic's production sites and enables the company to pursue its development by addressing multiple markets around the world, always with the highest level of service.

We are proud to remind you that our production sile has, since 2020, been producing SEPIMAX ZEN™, SEPINOV™ EMT 10, SEPINOV™ WEO, SIMULGEL™ NS, and SIMULGEL INS 100™. As a major worldwide player of rheology modifiers, Seppic group has a production footprint in the U.S. and is continuously investing in the U.S. in production assets.

We want to assure you of our commitment to providing high-quality products and services to our North American customers. Orders will continue to be placed as usual, our products will remain unchanged and you can expect the same level of excellence from us that you have come to expect over the years. Renaming Seppic's Richmond production sile reinforces Seppic's branding in the U.S. to support Seppic's strategy of offering a streamlined customer experience. Thank you for your conlinued support, and we look fof\vard to serving you as Seppic, Inc.


Seppic in brief

A subsidiary of Air Liquide Healthcare, Seppic designs, produces and distributes for 80 years a wide range of specialty ingredients for cosmetic, nutraceutical, pharmaceutical, veterinary and industrial products. Seppic employs close to 900 people worldwide, including 110 employees dedicated to innovation who develop effective ingredients with unique characteristics. Present in 100 countries through its subsidiaries and its network of distributors, Seppic aims to help everyone live well, and in good health in a healthy environment.www.seppic.com

Air Liquide Healthcare

AIr Liquide Healthcare supplies medical gases, home healthcare services, medical equipment and specialty ingredients.

In 2022, it served over 15,000 hospitals and clinics and more than 1.9 million patients at home throughout the world. The Group’s Healthcare business reached €3.9 billion in revenues in 2022, with the support of its 16,400 employees.

Zrzut ekranu 2022 01 26 o 12.38.58

Zurück nach oben